Boothbay Fund Management, LLC Opti Nose, Inc. Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.68 - $3.7 $90,194 - $198,641	53,687 New	53,687 $99,000
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.16 $26,707 - $35,913	-11,365 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.91 - $3.83 $33,072 - $43,527	11,365 New	11,365 $35,000
Q4 2019 Feb 14, 2020	SELL	$6.27 - $11.41 $163,653 - $297,812	-26,101 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.75 - $8.38 $123,979 - $218,726	26,101 New	26,101 $183,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $40M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.